Novel Illumina‐based next generation sequencing approach with one‐round amplification provides early and reliable detection of BCR‐ABL1 kinase domain mutations in chronic myeloid leukemia-Reference-Cited by-同舟云学术

Novel Illumina‐based next generation sequencing approach with one‐round amplification provides early and reliable detection of BCR‐ABL1 kinase domain mutations in chronic myeloid leukemia

Published:2020-02-09 Issue:3 Volume:189 Page:469-474
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Romzova Marianna¹²^ORCID,Smitalova Dagmar¹³^ORCID,Tom Nikola¹,Jurcek Tomas³⁴,Culen Martin¹³⁴^ORCID,Zackova Daniela⁴,Mayer Jiri¹³⁴,Racil Zdenek¹⁴

Affiliation:

1. Department of Molecular Medicine Central European Institute of TechnologyMasaryk University Brno Czech Republic

2. Department of Biochemistry Faculty of Medicine Masaryk University Brno Czech Republic

3. Department of Internal medicine, Hematology and Oncology Faculty of Medicine Masaryk University Brno Czech Republic

4. Internal Hematology and Oncology Clinic University Hospital Brno Brno Czech Republic

Funder

Ministry of Health

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16382

Reference15 articles.

1. Escherichia coli DNA polymerase III ε subunit increases Moloney murine leukemia virus reverse transcriptase fidelity and accuracy of RT–PCR procedures

2. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

3. Ultra-deep sequencing leads to earlier and more sensitive detection of the tyrosine kinase inhibitor resistance mutation T315I in chronic myeloid leukemia

4. The Tyrosine Kinase Inhibitor CGP57148B Selectively Inhibits the Growth of BCR-ABL–Positive Cells

5. Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of a novel NGS based BCR::ABL1 kinase domain mutation detection assay in Indian cohort;Scientific Reports;2024-07-08

2. Chronic myeloid leukemia kinase domain mutations: A retrospective descriptive study on the therapeutic and prognostic significance in patients at King Edward VIII Hospital, KwaZulu‐Natal, South Africa;Health Science Reports;2023-06-30

3. Imatinib Resistance in Chronic Myeloid Leukemia Associated with a D363G BCR::ABL1 Kinase Domain Mutation;Case Reports in Hematology;2023-04-20

4. A customized mass array panel for BCR::ABL1 tyrosine kinase domain mutation screening in chronic myeloid leukemia;Journal of Mass Spectrometry and Advances in the Clinical Lab;2023-04

5. Differences in Variants in the Structural Domain of <b><i>BCR-ABL1</i></b> Kinase between Chinese Han and Minority Patients with Chronic Myeloid Leukemia by Sanger Sequencing and Next-Generation Sequencing;Cytogenetic and Genome Research;2022